Indications and long-term outcome of treatment for benign hepatic tumors -A critical appraisal

Citation
T. Terkivatan et al., Indications and long-term outcome of treatment for benign hepatic tumors -A critical appraisal, ARCH SURG, 136(9), 2001, pp. 1033-1038
Citations number
42
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
ARCHIVES OF SURGERY
ISSN journal
00040010 → ACNP
Volume
136
Issue
9
Year of publication
2001
Pages
1033 - 1038
Database
ISI
SICI code
0004-0010(200109)136:9<1033:IALOOT>2.0.ZU;2-T
Abstract
Hypothesis: The natural history and clinical behavior of benign hepatic tum ors during long-term follow-up may not justify primary surgical treatment. Design: Retrospective study. Setting: Tertiary referral center. Patients: Two hundred eight patients diagnosed as having a benign liver tum or between January 1, 1979, and December 31, 1999. Intervention: Seventy-four patients underwent hepatic surgery and 134 were managed conservatively by radiological follow-up. Main Outcome Measures: Symptoms and complications were assessed during mana gement and follow-up. Results: In the surgically treated population, the liver lesion was symptom atic in 47 patients (64%) and an incidental finding in 27 (36%). The operat ive morbidity and mortality were 27% (20 of 74 patients) and 3% (2 of 74 pa tients), respectively. Overall, 28 (80%) of 35 patients with complaints wer e asymptomatic after surgery. During observation of the tumor in the conser vatively managed group, 39 (87%) of 45 patients who presented with complain ts were asymptomatic during a mean follow-up of 45 months; 6 patients had m ild abdominal pain considered to be unrelated to the tumor. Conclusions: Conservative management of solid benign liver lesions such as focal nodular hyperplasia and hemangioma can be performed safely, irrespect ive of their size. We only advise surgery for liver lesions when there is a n inability to exclude malignancy or in the case of severe complaints relat ed to the tumor. Resection is always advocated in the case of a large hepat ocellular adenoma (>5 cm) to reduce the risk of rupture and malignant degen eration.